Herpes simplex virus type 1 and 2 (HSV1 and HSV2) are global, widespread human pathogens transmitted by direct contact that cause lifelong, recurrent asymptomatic and painful symptomatic clinical illnesses (cold sores, keratitis, blepharitis, meningitis, encephalitis, genital infections), overt disease and severe sequelae in neonatal and immune-compromised patients, and increased risk of cervical cancer and other sexually transmitted infections, including HIV [...].
Vaccine development for herpes simplex viruses: A commentary of special issue editors
Caputo A.
Primo
;Marconi P.Ultimo
2021
Abstract
Herpes simplex virus type 1 and 2 (HSV1 and HSV2) are global, widespread human pathogens transmitted by direct contact that cause lifelong, recurrent asymptomatic and painful symptomatic clinical illnesses (cold sores, keratitis, blepharitis, meningitis, encephalitis, genital infections), overt disease and severe sequelae in neonatal and immune-compromised patients, and increased risk of cervical cancer and other sexually transmitted infections, including HIV [...].File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
vaccines-09-00158-v2.pdf
accesso aperto
Descrizione: editoriale
Tipologia:
Full text (versione editoriale)
Licenza:
Creative commons
Dimensione
180.82 kB
Formato
Adobe PDF
|
180.82 kB | Adobe PDF | Visualizza/Apri |
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.